Attended a Live Program?
Print Certificate
Publication Date: 23 June 2022
Human milk remains the gold standard nutrition source for infants' growth and development. It is rich in human milk oligosaccharides (HMOs), which may play a role in infants' digestive health and immune function. Improving the HMO profile of infant formulas to bridge the gap between human milk-fed and formula-fed infants is a continued effort. Five of the most abundant HMOs in human milk are 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), lacto-N-tetraose (LNT), 3′-sialyllactose (3′-SL) and 6′-sialyllactose (6′-SL). The goal of this study was to access the supplemental impact of 5 HMOs on growth, gastrointestinal (GI) tolerance and health outcomes in formula-fed infants.
This four-minute video provides a summary of the article Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial, available in the June 2022 issue of Nutrients (authors: John Lasekan, Yong Choe, Svyatoslav Dvoretskiy, Amy Devitt, Sue Zhang, Amy Mackey, Karyn Wulf, Rachael Buck, Christine Steele, Michelle Johnson, and Geraldine Baggs).
View the full article here.
You and your colleagues can stay connected to ANHI and events by subscribing to our monthly newsletter and other electronic communications.
Stay connected